title: Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [¹⁸F]fallypride study in cocaine dependent participants.
abstract: Drug-related cues are potent triggers for relapse in people with cocaine dependence. Dopamine (DA) release within a limbic network of striatum, amygdala and hippocampus has been implicated in animal studies, but in humans it has only been possible to measure effects in the striatum. The objective here was to measure drug cue-induced DA release in the amygdala and hippocampus using high-resolution PET with [(18)F]fallypride. Twelve cocaine-dependent volunteers (mean age: 39.6 ± 8.0 years; years of cocaine use: 15.9 ± 7.4) underwent two [(18)F]fallypride high-resolution research tomography-PET scans, one with exposure to neutral cues and one with cocaine cues. [(18)F]Fallypride non-displaceable-binding potential (BPND) values were derived for five regions of interest (ROI; amygdala, hippocampus, ventral limbic striatum, associative striatum, and sensorimotor striatum). Subjective responses to the cues were measured with visual analog scales and grouped using principal component analysis. Drug cue exposure significantly decreased BPND values in all five ROI in subjects who had a high-, but not low-, craving response (limbic striatum: p=0.019, associative striatum: p=0.008, sensorimotor striatum: p=0.004, amygdala: p=0.040, and right hippocampus: p=0.025). Individual differences in the cue-induced craving response predicted the magnitude of [(18)F]fallypride responses within the striatum (ventral limbic: r=0.581, p=0.048; associative: r=0.589, p=0.044; sensorimotor: r=0.675, p=0.016). To our knowledge this study provides the first evidence of drug cue-induced DA release in the amygdala and hippocampus in humans. The preferential induction of DA release among high-craving responders suggests that these aspects of the limbic reward network might contribute to drug-seeking behavior.
authors.affiliation: Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
authors.forename: Aryandokht
authors.initials: A
authors.lastname: Fotros
authors.forename: Kevin F
authors.initials: KF
authors.lastname: Casey
authors.forename: Kevin
authors.initials: K
authors.lastname: Larcher
authors.forename: Jeroen A J
authors.initials: JA
authors.lastname: Verhaeghe
authors.forename: Sylvia M L
authors.initials: SM
authors.lastname: Cox
authors.forename: Paul
authors.initials: P
authors.lastname: Gravel
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Reader
authors.forename: Alain
authors.initials: A
authors.lastname: Dagher
authors.forename: Chawki
authors.initials: C
authors.lastname: Benkelfat
authors.forename: Marco
authors.initials: M
authors.lastname: Leyton
mesh_terms: D000328:Adult; D000339:Affect; D000679:Amygdala / Q000000981:diagnostic imaging / Q000378:metabolism*; D016739:Behavior, Addictive / Q000000981:diagnostic imaging / Q000378:metabolism*; D001549:Benzamides; D019970:Cocaine-Related Disorders / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000523:psychology; D003342:Corpus Striatum / Q000000981:diagnostic imaging / Q000378:metabolism; D003463:Cues; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D005462:Fluorine Radioisotopes; D006624:Hippocampus / Q000000981:diagnostic imaging / Q000378:metabolism*; D006801:Humans; D008297:Male; D059906:Neuroimaging; D011877:Radionuclide Imaging
chemical_list: D001549:Benzamides; D005462:Fluorine Radioisotopes; C574003:fallypride; D004298:Dopamine
references.citation: Arch Gen Psychiatry. 2001 Apr;58(4):334-41
references.pmid: 11296093
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:33-48
references.pmid: 10415641
references.citation: J Neurosci. 2002 Feb 1;22(3):1126-36
references.pmid: 11826141
references.citation: Behav Neurosci. 1993 Feb;107(1):3-22
references.pmid: 8447956
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):12040-5
references.pmid: 8876259
references.citation: Drug Alcohol Depend. 2010 Sep 1;111(1-2):58-63
references.pmid: 20510552
references.citation: Horm Behav. 2009 May;55(5):646-54
references.pmid: 19446081
references.citation: Biol Psychiatry. 2011 Oct 15;70(8):785-793
references.pmid: 21757184
references.citation: Neuropsychopharmacology. 2003 Feb;28(2):329-38
references.pmid: 12589386
references.citation: Lancet. 1996 Feb 24;347(9000):504-8
references.pmid: 8596268
references.citation: Neurosci Biobehav Rev. 2003 Oct;27(6):543-54
references.pmid: 14599435
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):4-26
references.pmid: 19812543
references.citation: J Neurosci. 2007 Apr 11;27(15):3937-45
references.pmid: 17428967
references.citation: Science. 2010 Jul 30;329(5991):532
references.pmid: 20671181
references.citation: J Cereb Blood Flow Metab. 2011 Sep;31(9):1958-66
references.pmid: 21587267
references.citation: J Neurosci. 2007 Apr 11;27(15):3998-4003
references.pmid: 17428975
references.citation: Neuropsychopharmacology. 2003 Oct;28(10):1721-9
references.pmid: 12865896
references.citation: Physiol Behav. 2012 Jun 6;106(3):317-24
references.pmid: 22450260
references.citation: Psychopharmacology (Berl). 2001 Mar;154(3):301-10
references.pmid: 11351937
references.citation: Trends Cogn Sci. 2013 Feb;17(2):81-8
references.pmid: 23318095
references.citation: Neuropsychopharmacology. 2006 Dec;31(12):2728-38
references.pmid: 16598192
references.citation: J Nucl Med. 2012 Oct;53(10):1565-72
references.pmid: 22933820
references.citation: Neuroscience. 2005;135(4):1025-33
references.pmid: 16165291
references.citation: Prog Neurobiol. 2003 Apr;69(6):375-90
references.pmid: 12880632
references.citation: J Neurosci. 2005 Sep 21;25(38):8665-70
references.pmid: 16177034
references.citation: Neurobiol Learn Mem. 2002 Nov;78(3):625-36
references.pmid: 12559840
references.citation: Neuron. 2006 May 4;50(3):507-17
references.pmid: 16675403
references.citation: Addict Biol. 2014 Mar;19(2):240-9
references.pmid: 22458561
references.citation: Neuron. 2005 Feb 3;45(3):459-67
references.pmid: 15694331
references.citation: Behav Brain Res. 1997 Sep;87(2):139-48
references.pmid: 9331482
references.citation: Brain Res. 1990 Jul 2;522(1):69-75
references.pmid: 1977494
references.citation: Am J Psychiatry. 2001 Jan;158(1):86-95
references.pmid: 11136638
references.citation: NIDA Res Monogr. 1979;27:275-81
references.pmid: 95035
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4321-6
references.pmid: 10760299
references.citation: J Neurosci. 2012 Jan 18;32(3):1073-81
references.pmid: 22262905
references.citation: Synapse. 2002 Dec 1;46(3):170-88
references.pmid: 12325044
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):75-83
references.pmid: 12545331
references.citation: J Neurosci. 2012 May 2;32(18):6170-6
references.pmid: 22553023
references.citation: Nat Neurosci. 2003 May;6(5):526-31
references.pmid: 12704392
references.citation: J Cereb Blood Flow Metab. 2003 Mar;23(3):285-300
references.pmid: 12621304
references.citation: Behav Brain Res. 2001 Dec 14;127(1-2):13-23
references.pmid: 11718882
references.citation: Synapse. 2010 May;64(5):350-62
references.pmid: 20029833
references.citation: Int Rev Neurobiol. 2006;76:35-42
references.pmid: 17157641
references.citation: Addict Behav. 1998 Jul-Aug;23(4):449-61
references.pmid: 9698974
references.citation: Eur J Neurosci. 1998 Apr;10(4):1241-51
references.pmid: 9749778
references.citation: Neurobiol Learn Mem. 2007 May;87(4):688-92
references.pmid: 17337218
references.citation: Neuroscience. 2006;137(2):699-706
references.pmid: 16289883
references.citation: Biol Psychiatry. 2009 May 15;65(10):869-73
references.pmid: 18930184
references.citation: Trends Cogn Sci. 2010 Oct;14(10):464-72
references.pmid: 20829095
references.citation: Science. 2001 May 11;292(5519):1175-8
references.pmid: 11349151
references.citation: J Neurosci. 1995 Sep;15(9):5879-91
references.pmid: 7666173
references.citation: Behav Brain Res. 2009 Mar 2;198(1):1-12
references.pmid: 19022299
references.citation: Addict Behav. 1991;16(5):211-21
references.pmid: 1776539
references.citation: Exp Clin Psychopharmacol. 2001 Feb;9(1):3-13
references.pmid: 11519632
references.citation: Nature. 2011 Jan 6;469(7328):53-7
references.pmid: 21150898
references.citation: Neuropsychopharmacology. 2006 Dec;31(12):2716-27
references.pmid: 16971900
references.citation: Psychopharmacology (Berl). 2002 Jan;159(3):284-93
references.pmid: 11862361
references.citation: Curr Top Behav Neurosci. 2010;3:73-99
references.pmid: 21161750
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):391-431
references.pmid: 17072591
references.citation: Nat Neurosci. 2010 Apr;13(4):419-21
references.pmid: 20228805
references.citation: J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57
references.pmid: 11524609
references.citation: J Neurosci. 1998 Feb 15;18(4):1270-9
references.pmid: 9454837
references.citation: Neuroimage. 1997 Nov;6(4):279-87
references.pmid: 9417971
references.citation: J Neurosci. 2001 Apr 15;21(8):2851-60
references.pmid: 11306637
references.citation: Neuroimage. 2010 Feb 1;49(3):2536-43
references.pmid: 19913102
references.citation: Neuroimage. 2011 Jun 1;56(3):907-22
references.pmid: 21352927
references.citation: Nat Neurosci. 2005 Nov;8(11):1481-9
references.pmid: 16251991
references.citation: Br J Clin Pharmacol. 1991 Aug;32(2):167-72
references.pmid: 1931467
references.citation: Nat Neurosci. 2009 Oct;12(10):1224-5
references.pmid: 19718036
references.citation: J Neurosci. 2002 Jul 15;22(14):6247-53
references.pmid: 12122083
references.citation: J Neurosci. 2006 Jun 14;26(24):6583-8
references.pmid: 16775146
references.citation: Am J Psychiatry. 1999 Jan;156(1):11-8
references.pmid: 9892292
references.citation: Neuroimage. 1996 Dec;4(3 Pt 1):153-8
references.pmid: 9345505
references.citation: Trends Neurosci. 2008 Nov;31(11):552-8
references.pmid: 18786735
references.citation: Ann N Y Acad Sci. 2008 Oct;1141:1-21
references.pmid: 18991949
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):86-104
references.pmid: 19776728
references.citation: Behav Neurosci. 2005 Dec;119(6):1619-27
references.pmid: 16420164
references.citation: J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
references.pmid: 17519979
references.citation: Psychopharmacology (Berl). 1997 May;131(2):187-95
references.pmid: 9201808